Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.


We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, Pacific Biosciences has created a powerful technology platform called single molecule, real-time (SMRT™) technology. SMRT technology enables real-time analysis of biomolecules with single molecule resolution, which has the potential to transform the understanding of biological systems by providing a window into these systems that has not previously been open for scientific study.

FEATURED Event

Events & Presentations

2016 Bank of America Merrill Lynch Health Care Conference

May 10, 2016
Encore at the Wynn
Las Vegas

Read More »

Applying PacBio Long-Read Sequencing for Human Biomedical Research

Apr 28, 2016 at 4:00 PM PT

Read More »

Pacific Biosciences of California, Inc. First Quarter 2016 Earnings Conference Call

Apr 21, 2016 at 1:30 PM PT

Read More »

2016 AGBT General Meeting

Feb 10, 2016

Read More »

Recent News

Stock Quote

NASDAQ (GM): PACB
Price $9.43
Last Trade 4:00 PM ET
May 24, 2016
Change $-0.23
Change (%) -2.381%
Volume 1,101,903
52 Week High 14.00
52 Week Low 3.58
Day High 9.76
Day Low 9.36
Delayed at least 20 minutes.

Investor
Contact

Pacific Biosciences

1380 Willow Rd.

Menlo Park, Ca 94025

(650) 521-8450

ir@pacb.com